![Andre Aarøen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Andre Aarøen
Sociétés | Poste | Début | Fin |
---|---|---|---|
Flåmsbrygga Hotell AS
![]() Flåmsbrygga Hotell AS Hotels/Resorts/Cruise linesConsumer Services Flåmsbrygga Hotell AS is a private company based in Flåm, Norway. Flåmsbrygga Hotell AS operates hotels, boarding houses, and motels. The Norwegian company was founded in 2014 and is led by CEO Aud Melås. | Président | - | - |
Defibrio AS
![]() Defibrio AS Medical SpecialtiesHealth Technology Defibrio AS is a Norwegian company that focuses on saving lives by providing immediate access to automatic external defibrillators (AEDs). The company is based in Fana, Norway and was founded in 2020. The company's mission is to increase the survival rate of sudden cardiac arrest (SCA), which currently has a low survival rate of 10%%. SCA kills millions of people worldwide every year, with 70%% of deaths occurring in the home. Defibrio aims to reduce the chance of death by providing quick access to AEDs. The CEO is Arne Gjerde Bergby. | Président | - | - |
Historique de carrière de Andre Aarøen
Statistiques
Internationale
Norvège | 3 |
Opérationnelle
Chairman | 2 |
Sectorielle
Consumer Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Flåmsbrygga Hotell AS
![]() Flåmsbrygga Hotell AS Hotels/Resorts/Cruise linesConsumer Services Flåmsbrygga Hotell AS is a private company based in Flåm, Norway. Flåmsbrygga Hotell AS operates hotels, boarding houses, and motels. The Norwegian company was founded in 2014 and is led by CEO Aud Melås. | Consumer Services |
Defibrio AS
![]() Defibrio AS Medical SpecialtiesHealth Technology Defibrio AS is a Norwegian company that focuses on saving lives by providing immediate access to automatic external defibrillators (AEDs). The company is based in Fana, Norway and was founded in 2020. The company's mission is to increase the survival rate of sudden cardiac arrest (SCA), which currently has a low survival rate of 10%%. SCA kills millions of people worldwide every year, with 70%% of deaths occurring in the home. Defibrio aims to reduce the chance of death by providing quick access to AEDs. The CEO is Arne Gjerde Bergby. | Health Technology |
- Bourse
- Insiders
- Andre Aarøen
- Expérience